Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Mesalazine chemoprevention in high-risk recurrent sporadic colorectal adenoma
NL-OMON38274Phase 2Active, not recruiting
- Sponsor
- University Medical Center Utrecht
- Start
- Jul 2012
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of Salcrozine, sponsored by University Medical Center Utrecht. Started Jul 2012; status: active, not recruiting.
02
Drugs
Salcrozine
Beyond the preview
Go deeper on NL-OMON38274.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38274.